Table 2.

Bcl-2 and Bcl-X up-regulation upon PECAM-1 homophilic interaction

CellsBcl-2*Bcl-X*
CD14+CD34+ before adhesion 16 ± 10 6 ± 2  
CD14+CD34+ on D12P 100 ± 11 80 ± 13 
CD14+CD34+on D12P + anti–PECAM-1 F(ab′)2 6 ± 3 9 ± 2  
CD14+CD34+ on mock NIH3T3 20 ± 4 10 ± 2 
CellsBcl-2*Bcl-X*
CD14+CD34+ before adhesion 16 ± 10 6 ± 2  
CD14+CD34+ on D12P 100 ± 11 80 ± 13 
CD14+CD34+on D12P + anti–PECAM-1 F(ab′)2 6 ± 3 9 ± 2  
CD14+CD34+ on mock NIH3T3 20 ± 4 10 ± 2 
*

Bcl-2 and Bcl-X expression was evaluated by cytoplasmic immunofluorescence in CD14+CD34+ cells before or after 1-hour adhesion on D12P (PECAM-1+) or mock-transfected NIH3T3 monolayers, in the absence or presence of the F(ab′)2 of the specific anti–PECAM-1 mAb (5 μg/mL), collected after an additional 36 hours of culture. Cells were fixed in 2% paraformaldehyde, permeabilized with 0.01% NP-40, stained with the specific FITC anti–Bcl-2 or FITC anti–Bcl-X mAbs, and run on a FACSort. At least 104 cells per sample were analyzed and results plotted as arbitrary units (au) of mean fluorescence intensity (MFI, mean ± SD from 8 experiments). MFI of cells stained with an FITC-irrelevant mAb was 10 ± 5 au.

or Create an Account

Close Modal
Close Modal